Comprehensive evaluation research of Chinese patent medicine (CPM) is performed to demonstrate the comprehensive value of CPM from multiple dimensions and to clarify the clinical value and positioning, so as to provide references for decision-making in health or drug policies. Therefore, to standardize and promote comprehensive evaluation studies on CPM, the current guideline introduced the specific requirements on the applicable subject, basic principles, and major evaluation content, thereby providing guidance for researchers in the future.
Citation： Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Dongzhimen Hospital of Beijing University of Chinese Medicine, Guidelines and Standards Research Center of Chinese Medical Association Publishing House, China Information Association for Traditional Chinese Medicine and Pharmacy Clinical Research Information Association, Branch of Chinese Medicine of China Association for Standardization. Guideline for multi-dimensional and multi-criteria comprehensive evaluation of Chinese patent medicine. Chinese Journal of Evidence-Based Medicine, 2022, 22(7): 751-755. doi: 10.7507/1672-2531.202203100 Copy